December 11, 2018 Sophia Vida
Hot Stocks

Jim Cramer Said This of Moderna’s IPO Tumble

Shares of biotech company Moderna, which focuses on drug discovery and drug development based on messenger RNA, dropped nearly 20% on its opening debut in the market. Despite the drop, the company raised $604.3 million for an initial public offering, making it the biggest in biotech history. According to CNBC’s Jim Cramer, “There’s more to … Continue reading “Jim Cramer Said This of Moderna’s IPO Tumble”